Systematic overview of cost–effectiveness thresholds in ten countries across four continents
出版年份 2015 全文链接
标题
Systematic overview of cost–effectiveness thresholds in ten countries across four continents
作者
关键词
-
出版物
Journal of Comparative Effectiveness Research
Volume 4, Issue 5, Pages 485-504
出版商
Future Medicine Ltd
发表日期
2015-10-23
DOI
10.2217/cer.15.38
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Krebsfrüherkennung aus Sicht der Public-Health-Ethik
- (2014) G. Marckmann et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Communicating the Parameter Uncertainty in the IQWiG Efficiency Frontier to Decision-Makers
- (2014) Björn Stollenwerk et al. HEALTH ECONOMICS
- What is personalized medicine: sharpening a vague term based on a systematic literature review
- (2013) Sebastian Schleidgen et al. BMC Medical Ethics
- Technology Assessment for New Oncology Drugs
- (2013) B. Jonsson CLINICAL CANCER RESEARCH
- The Faces of Personalized Medicine: A Framework for Understanding Its Meaning and Scope
- (2013) W. Ken Redekop et al. VALUE IN HEALTH
- EUROPEAN DRUG REIMBURSEMENT SYSTEMS' LEGITIMACY: FIVE-COUNTRY COMPARISON AND POLICY TOOL
- (2012) Irina Cleemput et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- SIMILARITIES AND DIFFERENCES BETWEEN FIVE EUROPEAN DRUG REIMBURSEMENT SYSTEMS
- (2012) Margreet Franken et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Using health technology assessment for informing coverage decisions in Thailand
- (2012) Adun Mohara et al. Journal of Comparative Effectiveness Research
- Personalized Medicine: Progress and Promise
- (2011) Isaac S. Chan et al. Annual Review of Genomics and Human Genetics
- Setting Cost-Effectiveness Thresholds As A Means To Achieve Appropriate Drug Prices In Rich And Poor Countries
- (2011) Patricia M. Danzon et al. HEALTH AFFAIRS
- Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions
- (2011) Irina Cleemput et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Willingness to Pay per Quality-Adjusted Life Year: Is One Threshold Enough for Decision-Making?
- (2011) Fei-Li Zhao et al. MEDICAL CARE
- Drug approval challenges in the age of personalized cancer treatment
- (2011) Richard L Schilsky Personalized Medicine
- Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
- (2011) Q. Ma et al. PHARMACOLOGICAL REVIEWS
- Economic evaluation to inform health care decision-making: Promise, pitfalls and a proposal for an alternative path
- (2011) Astrid Brousselle et al. SOCIAL SCIENCE & MEDICINE
- Health technology assessments in personalized medicine: illustrations for cost–effectiveness analysis
- (2011) Maarten J Postma et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Health Technology Assessment and Private Payers' Coverage of Personalized Medicine
- (2011) Julia R. Trosman et al. Journal of Oncology Practice
- Payers and the Assessment of Clinical Utility for Companion Diagnostics
- (2010) B Quinn CLINICAL PHARMACOLOGY & THERAPEUTICS
- The efficiency frontier approach to economic evaluation of health-care interventions
- (2010) J. Jaime Caro et al. HEALTH ECONOMICS
- A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness
- (2010) Rodrigo Refoios Camejo et al. HEALTH POLICY
- When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology
- (2010) Dan Greenberg et al. JNCI-Journal of the National Cancer Institute
- Healthcare Rationing by Proxy
- (2010) John F.P. Bridges et al. PHARMACOECONOMICS
- Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis
- (2010) Martin Hoyle PHARMACOECONOMICS
- Comments on “Simoens, S. Health Economic Assessment: A Methodological Primer. Int. J. Environ. Res. Public Health 2009, 6, 2950-2966”—New Zealand in Fact Has No Cost-Effectiveness Threshold
- (2010) Scott Metcalfe et al. International Journal of Environmental Research and Public Health
- Health Economic Assessment: Cost-Effectiveness Thresholds and Other Decision Criteria
- (2010) Steven Simoens International Journal of Environmental Research and Public Health
- International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
- (2009) Takeru Shiroiwa et al. HEALTH ECONOMICS
- What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?
- (2009) R Scott Braithwaite et al. MEDICAL CARE
- How Much Are Americans Willing to Pay for a Quality-Adjusted Life Year?
- (2009) Milton C. Weinstein MEDICAL CARE
- Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer
- (2008) Mathias Lidgren et al. ACTA ONCOLOGICA
- The Role of Value for Money in Public Insurance Coverage Decisions for Drugs in Australia: A Retrospective Analysis 1994-2004
- (2008) Anthony H. Harris et al. MEDICAL DECISION MAKING
- The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond
- (2008) Angela Rocchi et al. VALUE IN HEALTH
- Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
- (2008) Scott D Grosse Expert Review of Pharmacoeconomics & Outcomes Research
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started